ENDO OPERATIONS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ENDO OPERATIONS, and when can generic versions of ENDO OPERATIONS drugs launch?
ENDO OPERATIONS has one hundred and twenty approved drugs.
There are twenty-four US patents protecting ENDO OPERATIONS drugs. There is one tentative approval on ENDO OPERATIONS drugs.
There are sixty-one patent family members on ENDO OPERATIONS drugs in thirty-eight countries and two hundred and seventy-three supplementary protection certificates in seventeen countries.
Summary for ENDO OPERATIONS
International Patents: | 61 |
US Patents: | 24 |
Tradenames: | 98 |
Ingredients: | 95 |
NDAs: | 120 |
Drugs and US Patents for ENDO OPERATIONS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Operations | TRAMADOL HYDROCHLORIDE | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200491-001 | Jun 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Endo Operations | BREVITAL SODIUM | methohexital sodium | INJECTABLE;INJECTION | 011559-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Endo Operations | GLYCOPYRROLATE | glycopyrrolate | TABLET;ORAL | 040653-001 | Aug 31, 2006 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ENDO OPERATIONS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Operations | TESTIM | testosterone | GEL;TRANSDERMAL | 021454-001 | Oct 31, 2002 | 5,023,252 | ⤷ Sign Up |
Endo Operations | TESTIM | testosterone | GEL;TRANSDERMAL | 021454-001 | Oct 31, 2002 | 7,935,690 | ⤷ Sign Up |
Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | 5,618,947 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ENDO OPERATIONS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 2.5 mg | ➤ Subscribe | 2011-03-09 |
➤ Subscribe | Gel | 10 mg/actuation | ➤ Subscribe | 2012-08-14 |
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
➤ Subscribe | Injection | 250 mg/mL | ➤ Subscribe | 2014-06-11 |
➤ Subscribe | Injection | 20 units/mL, 1 mL | ➤ Subscribe | 2018-03-23 |
➤ Subscribe | Gel | 1% | ➤ Subscribe | 2008-08-21 |
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
➤ Subscribe | Injection | 1 mg/mL ampules | ➤ Subscribe | 2016-03-09 |
International Patents for ENDO OPERATIONS Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Norway | 20054711 | ⤷ Sign Up |
Canada | 3093725 | ⤷ Sign Up |
Taiwan | I345976 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ENDO OPERATIONS Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3143995 | LUC00122 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: EVEROLIMUS OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/09/538/001, 003, 004, 006-010 20160530 |
0617614 | SPC/GB01/014 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: ALITRETINOIN; REGISTERED: UK EU/1/00/149/001 20001018 |
2435024 | 2021C/518 | Belgium | ⤷ Sign Up | PRODUCT NAME: UNE COMBINAISON DE FORMOTEROL (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES), GLYCOPYRROLATE (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES) ET BUDESONIDE (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES); AUTHORISATION NUMBER AND DATE: EU/1/20/1498 20201210 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.